Literature DB >> 28765179

Status epilepticus as the initial presentation of antibody-negative Goodpasture's syndrome.

Ingrid Pl Ting1, Sanihah Abdul Halim1, Azreen Adnan1, Hasnan Jaafar2.   

Abstract

Goodpasture's syndrome is a rare pulmonary-renal disease. It is characterised by presence of auto-antibodies directed against the glomerular basement membrane (GBM) antigen. These antibodies that bind to the GBM antigens cause rapidly progressive glomerulonephritis. The alveolar basement membrane also contains similar antigen, leading to pulmonary haemorrhage in active disease. We report a case of a young man who initially presented with status epilepticus and later was found to have rapidly progressive glomerulonephritis with pulmonary haemorrhage. Serum anti-GBM antibody was negative but the renal biopsy confirmed the diagnosis by showing typical linear IgG along the GBM on immunofluorescent study. He was treated with plasmapheresis and high-dose steroid in combination with oral cyclophosphamide. His renal function normalised after treatment. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  acute renal failure; epilepsy and seizures; renal medicine

Mesh:

Substances:

Year:  2017        PMID: 28765179      PMCID: PMC5612475          DOI: 10.1136/bcr-2017-219628

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  22 in total

1.  Goodpasture's disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques.

Authors:  Alan D Salama; Tammy Dougan; Jeremy B Levy; H Terry Cook; Steve H Morgan; Sarah Naudeer; Geoff Maidment; Andrew J T George; David Evans; Liz Lightstone; Charles D Pusey
Journal:  Am J Kidney Dis       Date:  2002-06       Impact factor: 8.860

2.  Anti-glomerular basement membrane disease.

Authors:  Charles D Pusey
Journal:  Kidney Int       Date:  2003-10       Impact factor: 10.612

3.  Posterior reversible encephalopathy syndrome in infection, sepsis, and shock.

Authors:  W S Bartynski; J F Boardman; Z R Zeigler; R K Shadduck; J Lister
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

4.  Cerebral vasculitis in a teenager with Goodpasture's syndrome.

Authors:  Nicola Gittins; Anna Basu; Janet Eyre; Anil Gholkar; Nadeem Moghal
Journal:  Nephrol Dial Transplant       Date:  2004-12       Impact factor: 5.992

5.  Landmark publication from The American Journal of the Medical Sciences: The significance of certain pulmonary lesions in relation to the etiology of influenza.

Authors:  Ernest W Goodpasture
Journal:  Am J Med Sci       Date:  2009-08       Impact factor: 2.378

Review 6.  Anti-glomerular basement membrane antibody disease: a rare autoimmune disorder affecting the kidney and the lung.

Authors:  Tobias Lahmer; Uwe Heemann
Journal:  Autoimmun Rev       Date:  2012-04-23       Impact factor: 9.754

7.  Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression.

Authors:  J B Levy; A N Turner; A J Rees; C D Pusey
Journal:  Ann Intern Med       Date:  2001-06-05       Impact factor: 25.391

8.  [Cerebral angiitis and Goodpasture's syndrome].

Authors:  P Garnier; C Deprele; B Pilonchéry; D Michel
Journal:  Rev Neurol (Paris)       Date:  2003-01       Impact factor: 2.607

9.  Imaging findings of central nervous system vasculitis associated with Goodpasture's Syndrome: a case report.

Authors:  Jee Young Kim; Kook Jin Ahn; Jung Im Jung; So Lyung Jung; Bum Soo Kim; Seong Tae Hahn
Journal:  Korean J Radiol       Date:  2007 Nov-Dec       Impact factor: 3.500

10.  The electron microscopy of the choroid plexus.

Authors:  D S MAXWELL; D C PEASE
Journal:  J Biophys Biochem Cytol       Date:  1956-07-25
View more
  1 in total

Review 1.  Goodpasture's autoimmune disease - A collagen IV disorder.

Authors:  Vadim Pedchenko; A Richard Kitching; Billy G Hudson
Journal:  Matrix Biol       Date:  2018-05-12       Impact factor: 11.583

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.